{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:53:28Z","timestamp":1790268808644,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>We performed a systematic review and meta-analysis on sodium benzoate\u2019s effects on cognitive function and other psychiatric symptoms in individuals with neuropsychiatric disorders. We searched PubMed, Embase, Cochrane Library, and PsychInfo databases until September 2023. A random-effects meta-analysis was performed within a frequentist framework. To investigate the potential sources of heterogeneity, we performed subgroup analyses based on sex, dose, diagnosis, and risk of bias of the included studies. Trial sequential analyses were performed to investigate the statistical power of the synthesized studies. The certainty in evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation approach. A total of 10 studies were included in the analysis. Sodium benzoate demonstrated a small-to-moderate positive effect on global cognitive function compared with placebo (standardized mean difference 0.40, 95% confidence interval 0.20 to 0.60, high certainty). Subgroup analyses suggested more pronounced effects in women; individuals receiving doses &amp;gt;500 mg\/day; and individuals with early-phase Alzheimer\u2019s disease, chronic schizophrenia, or major depressive disorder. Sodium benzoate also demonstrated potential efficacy in enhancing the speed of processing, working memory, verbal learning and memory, visual learning and memory, and reasoning and problem solving. Furthermore, sodium benzoate was effective for positive psychotic symptoms but not for negative psychotic and depressive symptoms with moderate certainty. The current evidence strongly supports the positive effects of sodium benzoate on cognitive function in neuropsychiatric disorders. Further research is required to confirm its efficacy across different subtypes or stages of neurocognitive disorders and within specific cognitive domains.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>PROSPERO, identifier CRD42023457462<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1370431","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:26:08Z","timestamp":1725841568000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Chun-Wei","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chih Meg","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/lm.2224411","article-title":"Aversive olfactory learning and associative long-term memory in Caenorhabditis elegans","volume":"18","author":"Amano","year":"2011","journal-title":"Learn Mem"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nn2005","article-title":"Specific requirement of NMDA receptors for long-term memory consolidation in Drosophila ellipsoid body","volume":"10","author":"Wu","year":"2007","journal-title":"Nat Neurosci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00052","article-title":"NMDA receptor activity in neuropsychiatric disorders","volume":"4","author":"Lakhan","year":"2013","journal-title":"Front Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02252617","article-title":"Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer\u2019s disease and vascular dementia","volume":"6","author":"Martinez","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(90)90051-5","article-title":"Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer\u2019s disease","volume":"38","author":"Lowe","year":"1990","journal-title":"Neuroscience"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90048-0","article-title":"Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer\u2019s disease","volume":"452","author":"Cowburn","year":"1988","journal-title":"Brain Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.11.009","article-title":"Possible role of D-serine in the pathophysiology of Alzheimer\u2019s disease","volume":"28","author":"Hashimoto","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"Lieberman","year":"2008","journal-title":"Pharmacol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4605971","article-title":"New treatment strategies of depression: based on mechanisms related to neuroplasticity","volume":"2017","author":"Huang","year":"2017","journal-title":"Neural Plast"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.biopsych.2011.10.034","article-title":"Clinical and cerebral volumetric effects of sodium benzoate, a D-amino acid oxidase inhibitor, in a drug-na\u00efve patient with major depression","volume":"71","author":"Lai","year":"2012","journal-title":"Biol Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.02.020","article-title":"Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression","volume":"74","author":"Huang","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2014.12.007","article-title":"Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings","volume":"61","author":"Levin","year":"2015","journal-title":"J Psychiatr Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118822157","article-title":"Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials","volume":"33","author":"Chang","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"22996","DOI":"10.1038\/s41598-021-02040-5","article-title":"Effect of N-methyl-D-aspartate receptor enhancing agents on cognition in dementia: an exploratory systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Chang","year":"2021","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2012.00822.x","article-title":"Contribution of serine racemase\/d-serine pathway to neuronal apoptosis","volume":"11","author":"Esposito","year":"2012","journal-title":"Aging Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/BF02259655","article-title":"The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats","volume":"9","author":"Pitk\u00e4nen","year":"1995","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(95)80004-L","article-title":"The effects of d-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks","volume":"5","author":"Pitk\u00e4nen","year":"1995","journal-title":"Eur Neuropsychopharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)37007-3","article-title":"Molecular cloning and chromosomal localization of a human gene encoding D-amino-acid oxidase","volume":"267","author":"Fukui","year":"1992","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114639109","article-title":"d-Amino acid oxidase controls motoneuron degeneration through d-serine","volume":"109","author":"Sasabe","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/bi963023s","article-title":"Limited proteolysis and X-ray crystallography reveal the origin of substrate specificity and of the rate-limiting product release during oxidation of D-amino acids catalyzed by mammalian D-amino acid oxidase","volume":"36","author":"Vanoni","year":"1997","journal-title":"Biochemistry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)83631-1","article-title":"Thermodynamic control of D-amino acid oxidase by benzoate binding","volume":"260","author":"Van den Berghe-Snorek","year":"1985","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.2159","article-title":"Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor","volume":"70","author":"Lane","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab001","article-title":"Brain activity of benzoate, a D-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, placebo controlled clinical trial","volume":"24","author":"Lane","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13504","article-title":"Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer\u2019s disease","volume":"77","author":"Lane","year":"2023","journal-title":"Psychiatry Clin Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115461","article-title":"Adjunctive transcranial direct current stimulation (tDCS) plus sodium benzoate for the treatment of early-phase Alzheimer\u2019s disease: A randomized, double-blind, placebo-controlled trial","volume":"328","author":"Lane","year":"2023","journal-title":"Psychiatry Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.08.010","article-title":"Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase alzheimer disease: A randomized, double-blind, placebo-controlled trial","volume":"75","author":"Lin","year":"2014","journal-title":"Biol Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2015.1117654","article-title":"Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial","volume":"18","author":"Lin","year":"2017","journal-title":"World J Biol Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.12.006","article-title":"Sodium benzoate, a D-amino acid oxidase inhibitor, added to clozapine for the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial","volume":"84","author":"Lin","year":"2018","journal-title":"Biol Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119849815","article-title":"Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial","volume":"33","author":"Lin","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S234371","article-title":"Precision medicine of sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD)","volume":"16","author":"Lin","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.6156","article-title":"Effect of sodium benzoate on cognitive function among patients with behavioral and psychological symptoms of dementia: secondary analysis of a randomized clinical trial","volume":"4","author":"Lin","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyac006","article-title":"Effects of sodium benzoate, a D-amino acid oxidase inhibitor, on perceived stress and cognitive function among patients with late-life depression: A randomized, double-blind, sertraline- and placebo-controlled trial","volume":"25","author":"Lin","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.24335","article-title":"Effect of sodium benzoate vs placebo among individuals with early psychosis: A randomized clinical trial","volume":"3","author":"Scott","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-023-03884-1","article-title":"Determination of D-serine and D-alanine tissue levels in the prefrontal cortex and hippocampus of rats after a single dose of sodium benzoate, a D-amino acid oxidase inhibitor, with potential antipsychotic and antidepressant properties","volume":"48","author":"Huang","year":"2023","journal-title":"Neurochem Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102947","article-title":"Efficacy and safety of add-on sodium benzoate, a D-amino acid oxidase inhibitor, in treatment of schizophrenia: A systematic review and meta-analysis","volume":"68","author":"Seetharam","year":"2022","journal-title":"Asian J Psychiatr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B41","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"B42","first-page":"728","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2021"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2018.05.005","article-title":"Interpretation of subgroup analyses in systematic reviews: A tutorial","volume":"7","author":"Richardson","year":"2019","journal-title":"Clin Epidemiol Global Health"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300881","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. What is the clinically relevant change on the ADAS-Cog","volume":"83","author":"Schrag","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S305331","article-title":"Clinically significant changes in the 17- and 6-item hamilton rating scales for depression: A STAR*D report","volume":"17","author":"Rush","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"B49","article-title":"Effects of clozapine on cognitive function in schizophrenia","author":"Lee","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2014.956082","article-title":"Augmentation strategies in partial responder and\/or treatment-resistant schizophrenia patients treated with clozapine","volume":"15","author":"Muscatello","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1822","article-title":"D-serine added to clozapine for the treatment of schizophrenia","volume":"156","author":"Tsai","year":"1999","journal-title":"Am J Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000165740.22377.6d","article-title":"Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results","volume":"25","author":"Diaz","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.5.826","article-title":"Placebo-controlled trial of glycine added to clozapine in schizophrenia","volume":"157","author":"Evins","year":"2000","journal-title":"Am J Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(98)00367-9","article-title":"A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia","volume":"45","author":"Goff","year":"1999","journal-title":"Biol Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1006\/enrs.1997.3782","article-title":"Estrogenic effects of p-hydroxybenzoic acid in CD1 mice","volume":"75","author":"Lemini","year":"1997","journal-title":"Environ Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1998.8544","article-title":"Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic","volume":"153","author":"Routledge","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7231915","article-title":"Investigating the interactive effects of sex steroid hormones and brain-derived neurotrophic factor during adolescence on hippocampal NMDA receptor expression","volume":"2018","author":"McCarthny","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2013.05.003","article-title":"Sex hormones modulate circulating antioxidant enzymes: impact of estrogen therapy","volume":"1","author":"Bellanti","year":"2013","journal-title":"Redox Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1080\/00048670903001943","article-title":"Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin\/ErbB4 and synapse regression","volume":"43","author":"Bennett","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-931483","article-title":"The neurochemical circuitry of schizophrenia","author":"Carlsson","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.66","article-title":"NMDA receptor genotypes associated with the vulnerability to develop dyskinesia","volume":"2","author":"Ivanova","year":"2012","journal-title":"Transl Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01045","article-title":"Antipsychotic treatment of behavioral and psychological symptoms of dementia (BPSD): management of extrapyramidal side effects","volume":"10","author":"Ohno","year":"2019","journal-title":"Front Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00105","article-title":"Sodium benzoate attenuates secondary brain injury by inhibiting neuronal apoptosis and reducing mitochondria-mediated oxidative stress in a rat model of intracerebral hemorrhage: possible involvement of DJ-1\/AKT\/IKK\/NF\u03baB pathway","volume":"12","author":"Xu","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22720","article-title":"Neuroprotective potential of cinnamon and its metabolites in Parkinson\u2019s disease: Mechanistic insights, limitations, and novel therapeutic opportunities","volume":"35","author":"Angelopoulou","year":"2021","journal-title":"J Biochem Mol Toxicol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/nu14071497","article-title":"Sodium benzoate-harmfulness and potential use in therapies for disorders related to the nervous system: A review","volume":"14","author":"Walczak-Nowicka","year":"2022","journal-title":"Nutrients"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.17085\/apm.21038","article-title":"Trial sequential analysis: novel approach for meta-analysis","volume":"16","author":"Kang","year":"2021","journal-title":"Anesth Pain Med (Seoul)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2023.12.010","article-title":"Efficacy and safety of collagen derivatives for osteoarthritis: A trial sequential meta-analysis","volume":"32","author":"Liang","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.3955","article-title":"D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: A systematic review and meta-analysis of individual participant data","volume":"74","author":"Mataix-Cols","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2017.12.006","article-title":"Cognitive behavioral therapy is associated with enhanced cognitive control network activity in major depression and posttraumatic stress disorder","volume":"3","author":"Yang","year":"2018","journal-title":"Biol Psychiatry Cognit Neurosci Neuroimaging"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1370431\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:26:15Z","timestamp":1725841575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1370431\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":69,"alternative-id":["10.3389\/fpsyt.2024.1370431"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1370431","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"article-number":"1370431"}}